← Leaderboards
William A See
University Of Iowa
$22,028
Attributed
$22,028
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $0 · FY2015–18$1$1$1$0$0
'15
'16
'17
'18
Funding mix
By agency
NIH$22,028 · 1
VA$0 · 1
By mechanism
M01$22,028 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- Peter S Thorne$26,236,012
- Donald D Heistad$11,093,459
- George J Weiner$29,916,936
- Frederick E Domann$2,914,825
- Yi Luo$2,974,456
Others in their field
Top investigators on “Clinical Treatment”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$502,840,370
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$440,177,135
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$397,337,077
Research focus
Clinical TreatmentAntihypertensive AgentsAntitumor EffectAdverse EffectsApoptoticAttenuatedBacillus (Bacterium)BaseAntitumor ResponseAffectBiological Adaptation To StressBladder NeoplasmCancer CellCancer PatientCancer PreventionCell Cycle ArrestCell InjuryCellsChemokineChemopreventionClinicClinical EfficacyClinical ResearchClinical Trials
Grant awards (7)
BCG-Induced Oxidative Stress as a Target for Improved Clinical Efficacy$0
I01 · FY2018 · VA · contact PI
BCG-Induced Oxidative Stress as a Target for Improved Clinical Efficacy$0
I01 · FY2017 · VA · contact PI
BCG-Induced Oxidative Stress as a Target for Improved Clinical Efficacy$0
I01 · FY2016 · VA · contact PI
BCG-Induced Oxidative Stress as a Target for Improved Clinical Efficacy$0
I01 · FY2015 · VA · contact PI
MEDICAL THERAPY AND BENIGN PROSTATE HYPERPLASIA$0
M01 · FY2002 · RR
MEDICAL THERAPY AND BENIGN PROSTATE HYPERPLASIA$0
M01 · FY2001 · RR
MEDICAL THERAPY AND BENIGN PROSTATE HYPERPLASIA$22,028
M01 · FY2000 · RR